The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
Market view
medroxyprogesterone acetate · Powder
24 marketed package NDCs · 12 active manufacturers
Most dispensed: 150 mg/mL · Injection, Suspension · #1 vial/carton / 1 ml in 1 vial · 150 mg/mL · Injection, Suspension · #25 vials/carton / 1 ml in 1 vial · 150 mg/mL · Injection, Suspension · #1 syringe/carton / 1 ml in 1 syringe · 10 mg · Tablet · #100 tablets/bottle
What changed in the last 90 days
Every detected change for medroxyprogesterone acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- ProveraSep 3, 2026New shortageby this manufacturerPfizer Inc.'s Provera (Tablet, 10 mg) is newly in shortage35 companies market provera
- ProveraSep 3, 2026New shortageby this manufacturerPfizer Inc.'s Provera (Tablet, 2.5 mg) is newly in shortage35 companies market provera
- Medroxyprogesterone AcetateSep 3, 2026New productRemedyrepack Inc.
- Medroxyprogesterone AcetateAug 19, 2026Price downNADAC $18.45812 → $18.31336 per unit (-0.78%)
- Medroxyprogesterone AcetateAug 19, 2026Price upNADAC $18.4128 → $22.84953 per unit (+24.1%)
- medroxyprogesterone acetateAug 19, 2026Price upNADAC $28.30894 → $28.49134 per unit (+0.64%)
- medroxyprogesterone acetateAug 19, 2026Price upNADAC $18.4128 → $22.84953 per unit (+24.1%)
- medroxyprogesterone acetateAug 19, 2026Price downNADAC $18.45812 → $18.31336 per unit (-0.78%)
- Medroxyprogesterone AcetateAug 19, 2026Price downNADAC $18.45812 → $18.31336 per unit (-0.78%)
- Medroxyprogesterone AcetateAug 19, 2026Price upNADAC $18.4128 → $22.84953 per unit (+24.1%)
Same drug class
Other molecules FDA puts in Progestin, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- drospirenone and estradiol· 1 maker
- estradiol and levonorgestrel· 1 maker
- estradiol/norethindrone acetate transdermal system· 1 maker
- etonogestrel and ethinyl estradiol vaginal ring· 1 maker
- junel fe· 1 maker
- levonorgestrel/ethinyl estradiol· 1 maker
- norelgestromin and ethinly estradiol· 1 maker
- segesterone acetate and ethinyl estradiol· 1 maker
- conjugated estrogens and medroxyprogesterone acetate· 2 makers
- estradiol/norethindrone acetate· 2 makers
- etonogestrel and ethinyl estradiol vaginal· 2 makers
- levonorgestrel tablet, 1.5 mg· 2 makers
Common questions
- Is Medroxyprogesterone acetate in shortage right now?
- No. FDA does not currently list Medroxyprogesterone acetate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Medroxyprogesterone acetate?
- 35 companies have marketed Medroxyprogesterone acetate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Medroxyprogesterone acetate cost?
- The typical pharmacy pays about $18.31 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.